title: Correlation between Banff classification, acute renal rejection scores, and reversal of rejection.
authors.affiliation: Department of Pathology, University of Tennessee-Memphis 38163.
authors.forename: L W
authors.initials: LW
authors.lastname: Gaber
authors.forename: L W
authors.initials: LW
authors.lastname: Moore
authors.forename: R R
authors.initials: RR
authors.lastname: Alloway
authors.forename: S
authors.initials: S
authors.lastname: Flax
authors.forename: A O
authors.initials: AO
authors.lastname: Gaber
mesh_terms: D000208:Acute Disease; D000961:Antilymphocyte Serum / Q000627:therapeutic use; D001379:Azathioprine / Q000627:therapeutic use; D003404:Creatinine / Q000097:blood; D016572:Cyclosporine / Q000627:therapeutic use; D006084:Graft Rejection / Q000145:classification* / Q000473:pathology* / Q000628:therapy; D006801:Humans; D007165:Immunosuppression Therapy / Q000379:methods; D016030:Kidney Transplantation / Q000276:immunology / Q000473:pathology*; D016853:Muromonab-CD3 / Q000627:therapeutic use; D013256:Steroids / Q000627:therapeutic use
chemical_list: D000961:Antilymphocyte Serum; D016853:Muromonab-CD3; D013256:Steroids; D016572:Cyclosporine; D003404:Creatinine; D001379:Azathioprine